Current landscape for T-cell targeting in autoimmunity and transplantation

Area of Science:

• Immunology
• Transplantation Medicine
• Autoimmune Diseases

Background:

• T-cell immunosuppressive strategies have revolutionized autoimmune disease management and solid organ transplantation.
• Autoimmune diseases affect millions, ranking third in mortality in developed nations.
• Solid organ transplantation offers a cure for end-stage organ diseases, with improving short-term outcomes.

Purpose of the Study:

• To review current T-cell immunosuppression clinical tools.
• To discuss strategies for inducing long-term T-cell tolerance.
• To explore future approaches for antigen-specific immunotherapies.

Main Methods:

• Literature review of current immunosuppressive strategies.
• Analysis of advances in T-cell tolerance induction.
• Discussion of emerging antigen-specific therapeutic agents.

Main Results:

• Short-term outcomes in transplantation and autoimmune disease management have improved.
• Long-term allograft survival and complete autoimmunity resolution remain challenging.
• Current immunosuppressants have significant adverse effects and associated morbidity/mortality.

Conclusions:

• While current immunosuppression has improved short-term outcomes, long-term efficacy and safety are limited.
• Developing short-acting, antigen-specific agents is crucial for optimizing clinical outcomes.
• Future research should focus on tolerance induction and targeted immunotherapies.